GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,969,000 | -0.9% | 137,114 | -0.9% | 0.40% | +32.8% |
| Q1 2022 | $6,026,000 | +26.2% | 138,340 | +27.8% | 0.30% | +40.4% |
| Q4 2021 | $4,774,000 | +15.4% | 108,247 | -0.1% | 0.21% | +10.4% |
| Q3 2021 | $4,138,000 | -4.1% | 108,305 | 0.0% | 0.19% | +3.2% |
| Q2 2021 | $4,313,000 | +11.2% | 108,305 | -0.3% | 0.19% | +3.9% |
| Q1 2021 | $3,877,000 | -2.9% | 108,620 | +0.2% | 0.18% | -24.1% |
| Q4 2020 | $3,991,000 | -2.2% | 108,444 | 0.0% | 0.24% | -3.7% |
| Q3 2020 | $4,082,000 | -7.9% | 108,444 | -0.1% | 0.25% | -10.5% |
| Q2 2020 | $4,430,000 | +7.4% | 108,602 | -0.2% | 0.28% | -1.8% |
| Q1 2020 | $4,125,000 | +267.6% | 108,861 | +318.4% | 0.28% | +1547.1% |
| Q2 2017 | $1,122,000 | +29.4% | 26,018 | +26.6% | 0.02% | +21.4% |
| Q1 2017 | $867,000 | +78.8% | 20,553 | +63.3% | 0.01% | +55.6% |
| Q4 2016 | $485,000 | – | 12,587 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |